Skip to content

Galapagos Cell Therapeutics

Active
Public limited company·Speur- en ontwikkelingswerk op biotechnologisch gebied· 1 yrs active
Schaliënhoevedreef 20T ·2800 Mechelen, Belgium
BE 1020.101.488
Watch Print / PDF

Conclusion

the dossier summarised in one paragraph

The computed 12-month bankruptcy probability of Galapagos Cell Therapeutics is 0.5% (low). The company has been active since 2025 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.

Based on State Gazette and CBE data.

Connections

21 connected companies
2-IMPROVE
via Peeters Guy · Permanent representative
PSH
via Peeters Guy · Director
ALGEMEEN ZIEKENHUIS KLINA
via Peeters Guy · Director
former
All 21 connections

Trust signals

3 signals
Young company
Founded in 2025 — under 3 years, statistically higher risk.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).

Administrative Flags

0 events
No administrative flags

Bankruptcy probability (12 mo)

Checked model v1 · free for everyone
0.5% Low
0%0,5%1,5%4%10%≥25%
Young company +Lower-failure-rate sector Lower-risk legal form

Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?

Company registry (CBE)

Crossroads Bank
Activities
Speur- en ontwikkelingswerk op biotechnologisch gebied72101Lease van intellectuele eigendom en vergelijkbare producten, met uitzondering van werken onder auteursrecht77400
Primary activity highlighted.
Names & trade names
Legal nameNL Galapagos Cell Therapeutics
Registered office
Schaliënhoevedreef 20T
2800 Mechelen, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.